Abivax Announced At-The-Market Program To Sell ADS For Up To $150M Over 3 Years

Benzinga11/20 05:52

Abivax Reports Liqyuduty Position

Seeking Alpha11/15 20:23

Abivax Q3 Total Principal Debt Outstanding €106.3M Down From €108.4M YoY

Benzinga11/15 06:12

Abivax Presents Third Quarter 2024 Key Financial Information

GlobeNewswire11/15 05:01

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

GlobeNewswire11/14 05:01

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of MicroRNA and Its Role in Post-Transcriptional Gene Regulation

GlobeNewswire10/08 04:01